What Do Clinical Trial Phases Mean? A Simple Guide for Families

If you've spent any time searching for Parkinson's clinical trials, you've probably noticed they all come with a phase number. Phase 1, Phase 2, Phase 3, sometimes even Phase 4.

Why Phases Exist

Before any new treatment reaches patients, researchers need to answer three basic questions. Is it safe? Does it work? Is it better than what we already have? Clinical trial phases are the structured way medicine answers those questions, one step at a time.

Phase 1: Is It Safe?

Phase 1 trials are the first time a new treatment is tested in people. The focus is almost entirely on safety. These trials are small, typically between 20 and 100 participants.

Phase 2: Does It Work?

Once a treatment clears Phase 1, researchers move on to the harder question. Phase 2 trials expand to a few hundred participants and start measuring whether the treatment has a real effect on the disease.

Phase 3: Is It Better?

Phase 3 is the final major hurdle before a treatment can be approved. These trials are large, often thousands of participants across multiple locations, comparing the new treatment directly against existing treatments or a placebo.

Phase 4: What Happens After Approval?

Phase 4 trials involve treatments that have already been FDA approved. Researchers continue studying them in larger, broader populations to monitor long term safety.

A Simple Way to Remember It

• Phase 1 — Is it safe?
• Phase 2 — Does it work?
• Phase 3 — Is it better than what we have?
• Phase 4 — What do we learn after approval?